Our study adds to the growing body of research by highlighting the potential utility of serological markers, specifically the TBE IgM Index and the TBE IgG/IgM Index, as tools for differentiating between severe and mild courses of TBE. The gene discussed is CD40LG; the disease is tick-borne encephalitis.